ProShares UltraShort Health Care
4 hedge funds and large institutions have $130K invested in ProShares UltraShort Health Care in 2025 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
31% more call options, than puts
Call options by funds: $9.24M | Put options by funds: $7.08M
0% more funds holding
Funds holding: 4 → 4 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
2.6% less ownership
Funds ownership: 9.76% → 7.16% (-2.6%)
68% less capital invested
Capital invested by funds: $403K → $130K (-$273K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$7.37K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$24 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IMC Chicago
Chicago,
Illinois
|
-$270K |
RXD Hedge Fund Activity: Q3 2025 in Review
4 of the 7,570 institutional investors tracked by Wall St. Rank reported a position in ProShares UltraShort Health Care (RXD) for Q3 2025, worth a combined $130K — down 68% from $403K a quarter earlier.
Fund positioning in RXD was balanced in Q3 2025: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $7.37K. The largest seller was IMC Chicago, exiting entirely with an estimated $270K sold.
- 4 institutional investors held ProShares UltraShort Health Care (RXD) as of Q3 2025, unchanged from Q2 2025.
- Funds reported $130K of ProShares UltraShort Health Care stock for Q3 2025, down 68% quarter-over-quarter.
- 1 fund opened new ProShares UltraShort Health Care positions in Q3 2025 and 1 closed out, a net change of 0 holders.
- The largest ProShares UltraShort Health Care buyer in Q3 2025 was Susquehanna International Group, an estimated $7.37K added.
- The largest ProShares UltraShort Health Care seller in Q3 2025 was IMC Chicago, an estimated $270K sold.
Based on aggregated 13F filings for Q3 2025.